Manchester, CTNCT06662162Now EnrollingIRB Ready

Age-Related Macular Degeneration Clinical Trial in Manchester, CT

Access cutting-edge age-related macular degeneration treatment through this clinical trial at a research site in Manchester. Study-provided care at no cost to qualified participants.

Sponsored by i-Lumen Scientific AUS PTY LTD

Quick Self-Assessment

See if you qualify for this Manchester location

Preparing your pre-screening questions…

Expert Care in Manchester

Access age-related macular degeneration specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related age-related macular degeneration treatment provided free

Apply for This Manchester Location

Check if you qualify for this age-related macular degeneration clinical trial in Manchester, CT

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Manchester

    Convenient for CT residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Manchester site if eligible
  4. 4Begin participation

About This Age-Related Macular Degeneration Study in Manchester

The goal of this clinical trial is to characterize the safety and effectiveness of the i-Lumen AMD transpalpebral microcurrent device and therapy in patients with intermediate to advanced nonexudative AMD. Participants will: * Undergo an initial loading regimen, followed by 7 maintenance over the course of 11 months. * Participants will return monthly through Month 14 (3 months post-last treatment) for evaluation and monitoring.

Sponsor: i-Lumen Scientific AUS PTY LTD

Who Can Participate

Inclusion Criteria

Presence of at least one large druse \>125 microns in diameter due to AMD.
BCVA letter score of 35 to 70 letters (inclusive) (Snellen equivalent 6/12 to 6/60 \[20/40 to 20/200\]) Key

Exclusion Criteria

Any implanted electrical device(s) including deep brain stimulator, hearing or visual implants (i.e., cochlear implant, auditory brainstem implant, retinal prostheses), and/or cardiac defibrillator/pacemaker.
Implanted metallic device within 20 cm of the Treatment electrode (study eye(s)) and/or the grounding electrode (base of the hairline on the back of the neck).
Uncontrolled diabetes, defined as glycated haemoglobin (HbA1c) \>10% (13.3 mmol/L).
Current tobacco or tobacco-related product use or history within the past 5 years of heavy smoking (defined as, on average, more than half a pack of cigarettes per day).
Known severe allergy to fluorescein dye.
Medical diagnosis of severe dry eye defined as requiring either artificial tears more than six (6) times a day or prescription drops (i.e., Restasis, Xiidra, or Cequa).
History of seizure disorders, chronic migraines and/or cluster headaches.
History and/or evidence of diabetic retinopathy in either eye as assessed by CF, fundus fluorescein angiography (FA), and OCT, to be confirmed by the Central Reading Centre.
Other conditions which pre-dispose to chorioretinal atrophy such as inherited retinal dystrophy (i.e., Stargardt's disease, Best's disease, pattern dystrophy, central areolar choroidal dystrophy, etc.).
History and/or evidence of exudative AMD in the study eye as assessed by CF, FA (or OCT-A ), and OCT, to be confirmed by Central Reading Centre.
GA involving the foveal centre, as assessed by the Central Reading Centre using AF and OCT.
History of intravitreal injections for GA (e.g., Syfovre or Izervay).
Treatment with photobiomodulation (PBM) therapy or short pulse laser within 12 months prior to screening.
Glaucoma requiring ≥3 medications and/or drops per day, or history of trabeculectomy.
History of any kind of intraocular surgery, excluding cataract surgery performed ≥3 months from Screening.
History of yttrium aluminium garnet (YAG) laser posterior capsulotomy \<1 month from Screening.
Visually significant cataracts and/or visually significant posterior capsular opacification.
History of amblyopia.

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Manchester?

Yes, this clinical trial (NCT06662162) has an active research site in Manchester, CT that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Age-Related Macular Degeneration Treatment Options in Manchester, CT

If you're searching for age-related macular degeneration treatment options in Manchester, CT, this clinical trial (NCT06662162) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Manchester research site is actively enrolling participants for this clinical trial. You'll receive care from experienced age-related macular degeneration specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all age-related macular degeneration clinical trials near you to find additional studies recruiting in your area.

More Rheumatoid Arthritis Trials in Manchester, CT

See all rheumatoid arthritis clinical trials recruiting in Manchester — not just this study.

Browse Rheumatoid Arthritis Trials in Manchester →

Browse More Trials by Condition

Rheumatoid Arthritis TrialsErectile Dysfunction TrialsMacular Degeneration TrialsWet Age-Related Macular Degeneration TrialsAll Conditions →

Ready to Join in Manchester?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Manchester, CT